Complications of poly implant prothèse breast implants: the current discussion
Against the background of the current discussion about Poly Implant Prothèse (PIP, Seyne-sur-mer, France) breast implants, we want to present a case demonstrating the complications such as implant rupture, silicone dissemination and level III silicone lymphadenopathy. A 29-year-old woman with cosme...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
09 Jan 2014
|
| In: |
Expert review of medical devices
Year: 2013, Volume: 10, Issue: 2, Pages: 167-170 |
| ISSN: | 1745-2422 |
| DOI: | 10.1586/erd.12.87 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1586/erd.12.87
|
| Author Notes: | Leila Kolios, Christoph Hirche, Alexander Spiethoff, Adrien Daigeler & Marcus Lehnhardt |
| Summary: | Against the background of the current discussion about Poly Implant Prothèse (PIP, Seyne-sur-mer, France) breast implants, we want to present a case demonstrating the complications such as implant rupture, silicone dissemination and level III silicone lymphadenopathy. A 29-year-old woman with cosmetic breast augmentation with PIP implants 5 years previously showed a sensitive swelling in her right axilla and neck region. All tests to detect an infectious or lymphomatous lymphadenopathy were negative. After ultrasound and MRI, rupture of the right implant was assumed and multiple pathologically enlarged lymph nodes up to supraclavicular region were shown. An excision biopsy of one axillary lymph node was performed; the histological examination detected a strong silicone lymphadenopathy. Surgical removal of both implants as well as capsulectomy was performed and 14 axillary lymph nodes up to level II were resected. Histologic evaluation confirmed the previous results. Our case underlines the actual discussion concerning increased rupture rate and massive silicone lymphadenopathy by PIP implants. The Agence Francaise de Sécurité Sanitaire des Produits de Santé (AFSSAPS) recommends clinical and ultrasound examination every 6 months for women with PIP implants. Any rupture, suspected rupture or leakage of prosthesis should lead to its explantation as well as that of the contralateral implant. In cases of unusual signs of inflammation, histological and immunohistochemical samples are to be taken. |
|---|---|
| Item Description: | published online: 09 Jan 2014 Gesehen am 25.03.2021 |
| Physical Description: | Online Resource |
| ISSN: | 1745-2422 |
| DOI: | 10.1586/erd.12.87 |